Science
Mechanism of Action
Naproxen exerts its effects by inhibiting cyclooxygenase (COX) enzymes, specifically both COX-1 and COX-2. This action blocks the synthesis of prostaglandins and thromboxanes from arachidonic acid, which are crucial biological compounds involved in initiating and propagating inflammation, pain, and fever responses in the body.
Research
Clinical Evidence
High confidence10%
Key findings
- 01 Topical naproxen 10% gel significantly reduced pain across various musculoskeletal conditions including lower back, knee, and cervical pain, muscle sprains, tendinitis, synovitis, and bursitis, demonstrating rapid and superior improvement from baseline scores. This topical route offers a potential alternative for patients aiming to reduce systemic side effects associated with oral NSAIDs.
- 02 Topical gel formulations of naproxen at 5% and 10% (w/w) exhibited comparable or enhanced penetration into muscle and skin tissues compared to a 10% w/w Naprosyn® gel, particularly when co-formulated with propylene glycol and polyethylene glycol. Utilizing non-sodium salts like naproxen ammonium further improved skin permeation and retention.
- 03 A 20% Naproxen Sodium Transdermal Cream is compounded for localized treatment of conditions such as osteoarthritis, rheumatoid arthritis, tendinitis, and bursitis, aiming to reduce systemic adverse effects commonly associated with oral NSAID administration.
Transparency
Dusting Analysis
Naproxen is primarily regulated as a pharmaceutical drug, specifically a nonsteroidal anti-inflammatory drug (NSAID), and is not typically classified or utilized as a cosmetic ingredient. Therefore, the concept of 'dusting' in a cosmetic context does not apply.
The Formula
Formulation
Stability
Naproxen demonstrates poor water solubility, although incorporating its salt forms (e.g., naproxen sodium or ammonium) can significantly enhance aqueous solubility and skin permeation. It is prone to autoxidation, particularly within mildly acidic to neutral pH environments (5.4-5.9). Optimal pH for topical gel stability is generally observed between pH 6 and pH 9, with some formulations performing best between pH 7 and pH 9. Enhancing chemical stability and skin compatibility can be achieved by adjusting formulations to a physiological pH range (5.5-6.5), integrating antioxidants, and utilizing oxygen-impermeable packaging.
Synergies
- Propylene glycol and polyethylene glycol for enhanced skin and muscle penetration.
- Non-sodium naproxen salts (e.g., naproxen ammonium) for improved skin permeation and retention.
- Antioxidants and oxygen-impermeable packaging for chemical stability.
Conflicts
- Certain neutralizing agents may react to form naproxen salts, leading to visible residue upon drying.
- Ethanol can disrupt polymer networks, potentially causing viscosity reduction or phase separation in formulations.
- Concurrent use with other NSAIDs (oral or topical), anticoagulants, antiplatelet drugs, or Selective Serotonin Reuptake Inhibitors (SSRIs) may elevate the risk of adverse effects, including bleeding.
Safety
Safety Profile
Naproxen is an FDA-approved pharmaceutical drug for managing pain, inflammation, and fever, not a cosmetic ingredient. While topical formulations are available up to 20%, local skin reactions and potential for systemic absorption are considerations. Significant drug interactions, particularly with other NSAIDs, anticoagulants, antiplatelet drugs, and SSRIs, are possible. The FDA advises against NSAID use, including naproxen, in pregnant women at 20 weeks gestation or later due to risks of fetal kidney problems.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While highly effective in topical applications for pain and inflammation relief, naproxen is primarily a pharmaceutical drug and has not been reviewed for cosmetic use, necessitating cautious and targeted application within a skincare brand.
Related
Similar Ingredients
Finding similar ingredients…